Patent details

Basic Information

Publication number:

EP3484477

PCT Application Number:

US2017042011

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP178284980

PCT Publication Number:

WO2018013862

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TREATMENT OF CANCER

French Title of Invention:

TRAITEMENT DU CANCER

German Title of Invention:

KREBSBEHANDLUNG

SPC Number:

Dates

Filing date:

13/07/2017

Grant date:

13/09/2023

EP Publication Date:

22/05/2019

PCT Publication Date:

18/01/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/09/2023

EP B1 Publication Date:

13/09/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

13/07/2024

Expiration date:

13/07/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/09/2023

 

 

Name:

Mingsight Pharmaceuticals, Inc.

Address:

P.O. Box 261208, San Diego, CA 92196, United States (US)

Inventor

1

Name:

ZHANG, Kai

Address:

United States (US)

2

Name:

NIESMAN, Michael

Address:

United States (US)

Priority

Priority Number:

201662362369 P

Priority Date:

14/07/2016

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/52; C07D 487/04; A61K 31/519; A61K 31/506; A61P 35/02; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:

202337

Publication date:

13/09/2023

Description:

Grant (B1)

2

Issue number:

202341

Publication date:

11/10/2023

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages